Drugs & medicalClass I

Biomerieux Inc recalls VITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REF 418984; b) AST-GN95, REF…

Ceftriaxone (cro02n) concentration errors associated with specific recently manufactured test kits which would have the potential for for false susceptible results. The risk is present for isolates that have a result…

Read the official notice →
Date
2024-05-01
Country
United States
Brand
Biomerieux
Product
VITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REF 418984; b) AST-GN95, REF…
Classification
Class I
Units
Worldwide
Category
Drugs & medical
Source
FDA · Device

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Biomerieux recalls

  1. 2026-07-15
  2. US
    Drugs & medicalClass II

    Biomerieux Inc recalls VITEK 2 AST-N447 TEST KIT Product reference 424620

    Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

    FDA · DeviceBiomerieux IncInternational distribution to the countries of Belgium and the Netherlands.Official notice →
  3. 2026-02-11
  4. US
    Drugs & medicalClass II

    Biomerieux Inc recalls VITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza02n) o Meropenem/Vaborbactam…

    Potential risk of Quality Control failures and/or false resistant antibiotic results when testing isolates of Enterobacterales/Enterobacteriaceae species and/or Pseudomonas aeruginosa with the identified antibiotic…

    FDA · DeviceBiomerieux IncWorldwide - US Nationwide distribution.Official notice →
  5. 2025-10-08
  6. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls VITEK¿ 2 Gram-negative AST Test Kits (Cards) containing Colistin formulation cs02n. VITEK¿ 2 is an automated system consisting of…

    Potential for false resistant results for Colistin (cs02n) with multi-drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii complex used in specific cards

    FDA · DevicebioMerieux, Inc.International distribution in the countries of Albania, Armenia, Australia,…Official notice →
  7. 2023-03-08
  8. US
    Drugs & medicalClass II

    Biomerieux Inc recalls MYLA comprises AST Filters in conjunction with VITEK MS; middleware which connects microbiology laboratory instruments for ID/AST and…

    For users with MYLA V4.8.X / V4.9 that use VITEK MS to identify organisms as part of their workflow, AST filter rules that have been activated are not always being applied to AST results when sending the results to the…

    FDA · DeviceBiomerieux IncUS Nationwide distribution to the states of Alabama, California, North…Official notice →
  9. 2023-01-11
  10. US
    Drugs & medicalClass II

    Biomerieux Inc recalls PPM LOMBARD PRODUCTS TSA 10PLT, CATALOG M1040

    As the temperature and time out of range was exceeded, product performances cannot be guaranteed

    FDA · DeviceBiomerieux IncUS Nationwide distribution.Official notice →
  11. 2022-10-05
  12. US
    Drugs & medicalClass II

    bioMerieux, Inc. recalls VIDAS CMV IgM, 30 tests, REF 30205-01, IVD, Rx.

    Invalid calibrations (out of range high) while using the product.

    FDA · DevicebioMerieux, Inc.Distribution was made to CA, FL, GA, IL, IN, LA, MA, MD, ME, MO, NJ, NY, OH,…Official notice →
All 16 Biomerieux recalls →

Other drugs & medical recalls in the United States

  1. 2024-05-01
  2. US
    Drugs & medicalClass II

    Ion Beam Applications S.A. recalls IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.

    There is a risk of mistreatment as irradiation is not prevented when some safety parameters are out of tolerance.

    FDA · DeviceIon Beam Applications S.A.US Nationwide distribution in the states of AR, FL, LA, KS, MI, TX, VA.Official notice →
  3. US
    Drugs & medicalClass II

    Abbott Molecular, Inc. recalls Alinity m System, Part Number: 08N53-002

    The Alinity m System camera detects whether tubes are "capped." If the camera detects a cap and the retention bar is not present on the sample rack, the system will generate the message 'Error - 6013: Has cap, no…

    FDA · DeviceAbbott Molecular, Inc.Worldwide distribution - US Nationwide and the countries ARGENTINA, AUSTRALIA,…Official notice →
  4. US
    Drugs & medicalClass II

    Siemens Medical Solutions USA, Inc. recalls ACUSON Redwood 1.0 Diagnostic Ultrasound System, REF: 11503314, running software version VA10A to VA10G

    On ultrasound systems, when Cardiac DICOM SR feature is configured to display either minimum or maximum measured value, and multiple cardiac region measurements are made, and results are exported into the SR feature,…

    FDA · DeviceSiemens Medical Solutions USA, Inc.Worldwide distribution - US Nationwide including in the states of AL, AR, CA,…Official notice →
  5. US
    Drugs & medicalClass II

    LEICA BIOSYSTEMS NUSSLOCH GMBH recalls Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED)

    There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set for created or…

    FDA · DeviceLEICA BIOSYSTEMS NUSSLOCH GMBHUS, NationwideOfficial notice →
  6. US
    Drugs & medicalClass II

    EPI Health, LLC recalls minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited,…

    CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

    FDA · DrugEPI Health, LLCUS NationwideOfficial notice →
  7. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,…

    Failed Dissolution Specifications

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide in the USA.Official notice →
See all drugs & medical recalls →